Literature DB >> 7814686

Loss of dopamine D2 receptors varies along the rostrocaudal axis of the hippocampal complex in Alzheimer's disease.

H L Ryoo1, J N Joyce.   

Abstract

The anatomy of the hippocampus, including the organization of its intrinsic neural circuits and afferents, is organized along a rostrocaudal axis. Dopamine D2 receptors are expressed in specific regions of the hippocampal complex (hippocampal subfields, entorhinal cortex, perirhinal cortex) and show differential expression along this axis. The dentate gyrus and CA3/CA4 subfields show higher numbers of D2 receptors in the rostral than in the caudal levels. In contrast, the subiculum shows the reverse gradient. We report here that Alzheimer's disease (AD) is associated with reduced expression of the dopamine D2 receptor, but the effects differ with respect to the rostrocaudal axis and area within the hippocampal complex. The number of D2 receptors is significantly reduced in the molecular layer of the dentate gyrus, CA3 subfield, and subiculum. For the dentate gyrus and subiculum, there were greater losses at more rostral levels. The CA3/CA4 subfields showed the greatest losses caudally. The entorhinal cortex, which shows only modest expression of D2 receptors in controls, does not exhibit reduced numbers in AD. The external laminae of the rostral perirhinal cortex showed more significant losses than more caudally in this cortical field. The regions showing loss of D2 receptors do not typically contain neuritic plaques, neurofibrillary tangles, or significant neuron loss. Thus other mechanisms must account for the unique gradient of D2 receptor loss in the hippocampus. The regions of reduced expression of dopamine D2 receptors do correlate well with the terminal zone of the dentate association pathway, the afferents from the amygdala and perirhinal cortex, and the sources of those afferents within the amygdala and perirhinal cortex. The specific patterns of reduced D2 receptor expression in AD are likely to contribute significantly to the disrupted information flow into and out of the hippocampus and, thus, of functions subserved by this system.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7814686     DOI: 10.1002/cne.903480105

Source DB:  PubMed          Journal:  J Comp Neurol        ISSN: 0021-9967            Impact factor:   3.215


  8 in total

1.  Neuron-specific age-related decreases in dopamine receptor subtype mRNAs.

Authors:  Scott E Hemby; John Q Trojanowski; Stephen D Ginsberg
Journal:  J Comp Neurol       Date:  2003-02-03       Impact factor: 3.215

Review 2.  Single cell gene expression profiling in Alzheimer's disease.

Authors:  Stephen D Ginsberg; Shaoli Che; Scott E Counts; Elliott J Mufson
Journal:  NeuroRx       Date:  2006-07

3.  Dopaminergic modulation of cortical plasticity in Alzheimer's disease patients.

Authors:  Giacomo Koch; Francesco Di Lorenzo; Sonia Bonnì; Viola Giacobbe; Marco Bozzali; Carlo Caltagirone; Alessandro Martorana
Journal:  Neuropsychopharmacology       Date:  2014-05-26       Impact factor: 7.853

4.  Periodic leg movements in sleep in elderly patients with Parkinsonism and Alzheimer's disease.

Authors:  D L Bliwise; L M Trotti; J A Yesavage; D B Rye
Journal:  Eur J Neurol       Date:  2012-02-16       Impact factor: 6.089

Review 5.  Target identification for CNS diseases by transcriptional profiling.

Authors:  C Anthony Altar; Marquis P Vawter; Stephen D Ginsberg
Journal:  Neuropsychopharmacology       Date:  2008-10-15       Impact factor: 7.853

6.  Volume alteration of hippocampal subfields in first-episode antipsychotic-naïve schizophrenia patients before and after acute antipsychotic treatment.

Authors:  Wenbin Li; Kaiming Li; Pujun Guan; Ying Chen; Yuan Xiao; Su Lui; John A Sweeney; Qiyong Gong
Journal:  Neuroimage Clin       Date:  2018-07-10       Impact factor: 4.881

7.  A Novel Based-Network Strategy to Identify Phytochemicals from Radix Salviae Miltiorrhizae (Danshen) for Treating Alzheimer's Disease.

Authors:  Bo Li; Yu-Rui Wu; Lan Li; Yu Liu; Zhu-Yun Yan
Journal:  Molecules       Date:  2022-07-12       Impact factor: 4.927

Review 8.  Single-cell gene expression analysis: implications for neurodegenerative and neuropsychiatric disorders.

Authors:  Stephen D Ginsberg; Irina Elarova; Marc Ruben; Fengzhu Tan; Scott E Counts; James H Eberwine; John Q Trojanowski; Scott E Hemby; Elliott J Mufson; Shaoli Che
Journal:  Neurochem Res       Date:  2004-06       Impact factor: 3.996

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.